Related Experiment Video
Updated: Apr 23, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Macrocyclic peptides as protein-protein interaction modulators: a review
Erin Ann Sunny1, Sandhya Sadanandan1
1Department of Chemistry, School of Advanced Sciences, VIT-AP University, Amaravati, Andhra Pradesh 522241, India. sandhya.sadanandan@vitap.ac.in.
Macrocyclic peptides offer a promising strategy for targeting challenging protein-protein interactions (PPIs) that are difficult for small molecules to address. These cyclic peptides are advancing precision medicine for various diseases.
Area of Science:
- Biochemistry and Molecular Biology
- Drug Discovery and Development
- Medicinal Chemistry
Background:
- Protein-protein interactions (PPIs) are crucial for cellular functions but are difficult to target with conventional drugs due to their large, dynamic interfaces.
- Macrocyclic peptides represent a novel therapeutic modality, bridging the gap between small molecules and biologics.
- Conformational constraint in peptides, achieved through natural cyclic peptides and phage display, enhances affinity and stability.
Purpose of the Study:
- To review emerging strategies for discovering macrocyclic peptide-based modulators of protein-protein interactions (PPIs).
- To highlight the application of these modulators in targeting diverse diseases, including oncology, infectious diseases, and inflammatory conditions.
- To discuss future directions in peptide-based drug development for PPIs.
Main Methods:
- Literature review of recent advancements in macrocyclic peptide drug discovery for PPIs.
- Exploration of high-throughput screening, structure-based drug design, and artificial intelligence in identifying peptide therapeutics.
- Analysis of chemical modification techniques (e.g., stapling, unnatural amino acids) to enhance peptide properties.
Main Results:
- Macrocyclic peptides demonstrate high specificity and affinity for targeting extended protein surfaces.
- Successful targeting of disease-driving PPIs like MDM2-p53, BCL-2 family, and KRAS-effector complexes is evident.
- Chemical modifications improve peptide stability, proteolytic resistance, and cell permeability.
Conclusions:
- Macrocyclic peptides are a versatile platform for developing novel therapeutics against challenging PPI targets.
- These peptide-based drugs hold significant potential for expanding precision medicine applications across various diseases.
- Continued innovation in discovery and modification techniques will drive the future of PPI-directed peptide therapeutics.
Related Concept Videos
Protein-protein Interfaces
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

